May 06, 2008 - Merck Extends Deadline for Vioxx Registrants to Submit Proof
May 6, 2008 - Merck & Company, maker of Vioxx, the drug which is the subject of a recent $4.85 billion dollar settlement proposal, has extended the deadline for claimants made ill by the drug to submit their paperwork.
Merck agreed to the $4.85 billion settlement in November of last year, in order to bring an end to the approximately 61,100 lawsuits involving Vioxx. Eligible claimants who took Vioxx and subsequently suffered a heart attack or stroke were originally given a May 1st deadline to submit proof. As of March 31st, approximately 45,000 claimants had registered, and with the paperwork for those claimants still not verified and more paperwork arriving each day, Merck made the decision to extend the deadline to June 30th.
Lawyers on the steering committee for the plaintiffs said that the extension raised no concerns for them. They said that they had anticipated it, given the rate at which new documents have been arriving each day.
Merck pulled Vioxx from the market on Sept. 30, 2004, amid evidence the blockbuster drug doubled risk of heart attack and stroke.
<< back
|
The above is not legal advice. That can only come from a qualified attorney
who is familiar with all the facts and circumstances of a particular, specific
case and the relevant law. See Terms
of Use.
The law firm of Harold D. Carr is not responsible for information contained in any links to other websites from this site.
Links are provided for educational information only and may not apply to your specific circumstance.
It is possible for information on other links to be inaccurate or misleading. You are cautioned to exercise extreme care when using any resource link.
For specific legal advice regarding your specific case contact the law firm of Harold D. Carr at 1 800 700 8082.
|
